CLOs on the Move


 
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Unisyn Medical Technologies

Unisyn Medical Technologies is a Golden, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

University of Connecticut Health Center

The UConn Health Center offers an impressive range of clinical services by more than 350 physicians in over 50 specialties on an outpatient basis and on an inpatient basis at John Dempsey Hospital.

PT Plus

Providing cutting edge therapeutic solutions to you, your family and friends.

Bostwick Laboratories Inc

Bostwick Laboratories, Inc. a specialized anatomic pathology laboratory focused on the diagnosis of cancer. The Company delivers diagnostic reports providing physicians with the ability to make treatment decisions with their patients.

Injury Care Associates

Injury Care Associates is a physician-led occupational health clinic that specializes in helping employees get back to work and back to life after an injury. They offer workers compensation and employee health services in the Denver metro area.